Evidence map›Paper›PMID 23871731›Full record

Trial reportThe Journal of pediatrics2013

Cerebral hyperemia measured with near infrared spectroscopy during treatment of diabetic ketoacidosis in children.

Nicole S Glaser, Daniel J Tancredi, James P Marcin, Ryan Caltagirone, Yvonne Lee, Christopher Murphy, Nathan Kuppermann

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Pediatric diabetic ketoacidosis and cerebral oedema: a systematic review.Annals of pediatric endocrinology & metabolism · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Cerebrovascular autoregulation in diabetic ketoacidosis: time to go with the (microvascular cerebral blood) flow!Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2014
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nicole S GlaserDepartment of Pediatrics, University of California Davis, School of Medicine, Sacramento, CA. Electronic address: nsglaser@ucdavis.edu.
Daniel J Tancredi
James P Marcin
Ryan Caltagirone
Yvonne Lee
Christopher Murphy
Nathan Kuppermann
University of California, Davis · US

Funding

Cerebral edema in pediatric ketoacidosisR01NS048610 · NINDS · UNIVERSITY OF CALIFORNIA DAVIS · PI GLASER, NICOLE S · 2005 to 2009
$1.5M
NINDS NIH HHS R01 NS048610
6 · The paper itself

Abstract

objectiveTo use near infrared spectroscopy (NIRS) to evaluate the timing of onset and duration of cerebral hyperemia during diabetic ketoacidosis (DKA) treatment in children, and to investigate the relationship of cerebral hyperemia to intravenous fluid treatment. STUDY

designWe randomized children aged 8-18 years with DKA to either more rapid or slower intravenous fluid treatment (19 total DKA episodes). NIRS was used to measure rSo2 during DKA treatment. NIRS monitoring began as soon as informed consent was obtained and continued until the patient was transferred out of the critical care unit.

resultsrSo2 values above the normal range (>80%) were detected in 17 of 19 DKA episodes (mean rSo2 during initial 8 hours of DKA treatment: 86% ± 7%, range 65%-95%). Elevated rSo2 values were detected as early as the second hour of DKA treatment and persisted for as long as 27 hours. Hourly mean rSo2 levels during treatment did not differ significantly by fluid treatment group.

conclusionsDuring DKA treatment, children have elevated rSo2 values consistent with cerebral hyperemia. Hyperemia occurs as early as the second hour of DKA treatment and may persist for ≥ 27 hours. Cerebral rSo2 levels during treatment did not differ significantly in patients treated with slower versus more rapid intravenous rehydration.

Indexed as

Spectroscopy, Near-InfraredAdolescentBrainCerebrovascular CirculationCerebrovascular DisordersChildDiabetic KetoacidosisFemaleFluid TherapyHumansHyperemiaInfusions, IntravenousLinear ModelsMaleTime FactorsCBFCerebral blood flowDiabetic ketoacidosisDKAMagnetic resonance imagingMRINear infrared spectroscopyNIRSRegional cerebral oxygen saturationrSo(2)

Identifiers

PMID23871731
PMCPMC3792791
OpenAlexW2128476997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.